Malaria News and Research

Latest Malaria News and Research

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Genvec to sell 8,000,000 shares to develop its TNFerade clinical program

Genvec to sell 8,000,000 shares to develop its TNFerade clinical program

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Movember to present at the LIVESTRONG Global Cancer Summit

Movember to present at the LIVESTRONG Global Cancer Summit

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

$201,339 grant offered to a professor for developing a database on enzyme functions

$201,339 grant offered to a professor for developing a database on enzyme functions

Aid agencies seek to access displaced Yemenis at 'high risk' of disease outbreaks

Aid agencies seek to access displaced Yemenis at 'high risk' of disease outbreaks

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

PLoS journal throws light on neglected tropical diseases toll in sub-Saharan Africa

PLoS journal throws light on neglected tropical diseases toll in sub-Saharan Africa

Recent releases: limiting corruption; mental health; U.S. global health policies; non-physician administered ARV; African health ministers

Recent releases: limiting corruption; mental health; U.S. global health policies; non-physician administered ARV; African health ministers

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

WHO recommends against using homeopathic treatments for HIV, TB, malaria, influenza, infant diarrhea

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

New antimalarial drug discovery project funded by European Commission

New antimalarial drug discovery project funded by European Commission

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.